From "Wow" to "How": What your questions taught us about the future of AI in clinical trials

We recently hosted a webinar at CRScube to showcase our AI-led EDC setup, a functionality designed to automatically configure eCRFs and edit checks directly from a CRF specification or protocol.

While the technology itself is a leap forward, the real story wasn't just in the demo; it was in the Q&A session. As we scrolled through the questions, a clear picture emerged. The clinical research industry is moving past the "shiny object" phase of AI and into a phase of pragmatic scrutiny.

The audience isn't asking if AI works; they are asking how it survives the messy, regulated, and unpredictable reality of a live clinical trial. Here is what your questions revealed about the state of AI readiness in our industry. 

1. The "Human-in-the-Loop" security blanket

One of the most telling questions was:

"Can we manually create CRF pages in certain scenarios where AI does not work?"

We believe it reflects a healthy scepticism. Even when presented with automation that can handle the heavy lifting, Data Managers (DMs) want to know they still have the keys to the car.

What this tells us: Users are not looking for a "black box" that operates in isolation; they are looking for an augmented workflow. While they want to use AI, they also want the option to be hands-on. It aligns perfectly with our goal: we are not looking to replace human expertise; we want to liberate you from the inefficiency of manual entry while keeping you in the driver's seat for complex edge cases.

2. Guardrails, not just go-fast buttons

Questions regarding quality and logic were high on the priority list:

"If the CRF specifications contain obvious typos or contradictions, how will the AI process them? Will the AI provide feedback on the specifications themselves?"

This is a sophisticated question. It shows the audience understands that garbage in equals garbage out. The expectation of AI is not only to follow instructions, but also to be "smart" enough to raise its hand when something doesn't look right.

What this tells us: Readiness for AI is tied to data integrity. The audience expects AI to act as a first-line quality control filter, identifying contradictions in the documents (protocol or CRF specification) before they are widely shared.

3. The seal of approval

No clinical innovation survives without addressing the regulatory framework. We saw several variations of this question:

"How do you ensure that validation is being performed when AI leads the EDC? Will the validation process (UAT) change?"

What this tells us: There is a lingering (and valid) anxiety about how 21 CFR Part 11 and traditional UAT (User Acceptance Testing) models adapt to AI. Innovation is great, but compliance is non-negotiable. For AI to be fully embraced, the validation output must be as robust as the automation output.

4. The evolution of the Data Manager

Finally, there was the elephant in the room:

"Will this reduce opportunities for DMs?"

This question hits at the heart of the "AI anxiety" prevalent in many industries. However, the tone of the webinar wasn't one of fear, but of evolution.

What this tells us: The role of the Data Manager is shifting from "Builder" to "Architect." Instead of spending weeks manually mapping fields and writing repetitive edit checks, the DM of the future will focus on strategy, complex data trends, and oversight. We are strong believers that the "opportunity" isn't disappearing; it’s being elevated.

The verdict: Are we ready?

The questions asked during our session show an audience that is cautiously optimistic and highly practical. It was very refreshing to see that people are not looking for magic; they are looking for efficiency that respects the rules. It aligns perfectly with our focus on Practical AI: purpose-built functionalities that transform processes with precision. In EDC, AI serves as a high-performance engine for the foundational setup, allowing teams to focus their expertise on the strategic complexities of the protocol and the ultimate integrity of the study.

The future of EDC we have in mind isn't just about AI building forms; it's about AI and humans building better trials, together.

If you missed the webinar, you can watch it on-demand here.